Immorta Bio and Collaborators Publish Blueprint for the Future of AI-Driven Precision Medicine

New Journal of Translational Medicine Perspective outlines how AI, multi-omics, digital twins, and blockchain can transform P4 Medicine into clinical reality. MIAMI, July 21, 2026 /PRNewswire/ -- Immorta Bio today announced the publication of a peer-reviewed Perspective article in the...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.